The forecast for hospital discharges due to malignant neoplasm of the skin in France shows a consistent decline from 2024 to 2028. In 2023, the actual number of discharges stood at approximately 16.98 thousand, marking the base year before the forecast. The year-on-year percentage variation reveals a persistent downward trend, averaging a decrease of around 5% annually across the five-year period, translating into a Compound Annual Growth Rate (CAGR) of approximately -5.2%.
Future trends to watch for include potential advances in early detection and treatment modalities, public health initiatives aimed at prevention, and demographic changes that might influence hospitalization rates. Continuous monitoring of these factors is crucial to refine forecasts and healthcare planning.
